VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,451 | -90.4% | 33,500 | -85.7% | 0.00% | – |
Q3 2022 | $36,000 | -92.9% | 234,400 | -42.8% | 0.00% | -100.0% |
Q1 2022 | $508,000 | -73.9% | 410,000 | -59.0% | 0.00% | -80.0% |
Q4 2021 | $1,948,000 | -35.9% | 998,800 | -10.0% | 0.01% | -37.5% |
Q3 2021 | $3,040,000 | +52.9% | 1,109,500 | +75.8% | 0.01% | +60.0% |
Q2 2021 | $1,988,000 | +32.3% | 631,000 | -10.6% | 0.01% | +25.0% |
Q1 2021 | $1,503,000 | +553.5% | 705,700 | +496.5% | 0.00% | +300.0% |
Q4 2020 | $230,000 | +1050.0% | 118,300 | +310.8% | 0.00% | – |
Q3 2020 | $20,000 | – | 28,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $32,135,000 | 11.34% |
VR Adviser, LLC | 16,047,286 | $43,970,000 | 5.65% |
COMMODORE CAPITAL LP | 5,123,509 | $14,038,000 | 3.70% |
Ghost Tree Capital, LLC | 2,000,000 | $5,480,000 | 1.60% |
EPIQ PARTNERS, LLC | 916,100 | $2,510,000 | 1.16% |
SILVERARC CAPITAL MANAGEMENT, LLC | 707,733 | $1,939,000 | 1.10% |
SPHERA FUNDS MANAGEMENT LTD. | 3,824,938 | $10,480,000 | 0.88% |
HighVista Strategies LLC | 438,239 | $1,201,000 | 0.80% |
Nicholas Investment Partners, LP | 2,786,354 | $7,635,000 | 0.56% |
NEA Management Company, LLC | 16,302,596 | $44,669,000 | 0.53% |